NEW YORK--(BUSINESS WIRE)--PM360's 13th Annual Innovations Issue recognizes Swoop for its cutting-edge contributions to data-driven healthcare marketing. Honored with three prestigious innovation awards for its pioneering contributions to the healthcare marketing sector, Swoop is committed to transforming patient engagement throughout their health journey and improving their health outcomes through innovative technologies.

In its 13th year, PM360's Innovations Issue is recognized as the industry's premier guide to the year's most innovative advancements. Swoop's inclusion highlights its role in transforming omnichannel marketing by anticipating key health events in a privacy-safe way and connecting patients and healthcare providers (HCPs) across their health journey. "We are thrilled to receive this triple recognition from PM360," said Simeon Simeonov, Swoop Co-Founder and Chief Technology Officer. "These awards highlight the groundbreaking work our team is doing in healthcare marketing and our commitment to innovating solutions that revolutionize omnichannel marketing in healthcare. We're not just enhancing marketing effectiveness, we're improving patient outcomes and the entire healthcare landscape."

Honored by the publication across categories, Swoop's Predictive Adherence Audiences, HCP Pro Suite, and Swoop Piper are pushing the pharmaceutical industry forward and accelerating targeted reach to improve health outcomes.

Predictive Adherence Audiences

One of the greatest challenges for patients is maintaining adherence and continuing their medication as prescribed. According to a KFF Health Tracking Poll, 100% of patients that stop treatment prematurely report their condition worsens. Swoop's groundbreaking predictive adherence audience solution goes beyond typical diagnosed patient segments to help pharmaceutical marketers influence patient behavior and improve health outcomes. This privacy-compliant targeting methodology allows healthcare advertisers to predict and engage with patient populations who may be most likely to become non-adherent within 45 days. By reaching these patients and their doctors in tandem, brands can deliver targeted messaging that results in timely interventions, ultimately enhancing quality of life and care.

HCP Pro Suite

Launched in September 2024, the Swoop HCP Pro Suite revolutionizes how pharmaceutical marketers engage with HCPs by helping them understand and identify their most valuable HCPs. This innovation transcends traditional NPI targeting with AI-driven insights into HCPs' behaviors and preferences, enabling marketers to deliver personalized, omnichannel communications. This innovation improves engagement, reduces waste, and elevates prescription lift by identifying high-value HCPs so brand marketers can coordinate targeted outreach.

Swoop Piper

The Swoop Piper Generative AI (GenAI) platform enables healthcare marketers to interact with target audiences and segment data through AI Assistants. This innovation facilitates optimized decision-making by providing comprehensive data analysis, helping marketers accelerate decision making, deliver more effective campaigns, and bridge the gap between sales and customers.

Swoop's triple innovation win serves as a testament to our prioritization of advancing healthcare. By driving innovation, we equip marketers with the tools they need to target more effectively, leading to greater efficiency. Our pioneering efforts are pivotal steps toward realizing our omnichannel vision — anticipating key health events in a privacy-safe manner and seamlessly connecting patients and providers across all channels. This holistic approach not only transforms the marketing landscape but can also impact patients' lives, so they receive the right care at the right time.

About Swoop

Swoop is a leading provider of precision AI-driven healthcare omnichannel solutions dedicated to protecting consumer privacy. By prioritizing privacy and compliance, Swoop ensures the highest standards of data protection for its clients and partners. Our superior audience quality segments and 100% MLR-approved conversational AI agents generate meaningful patient and provider engagement, optimal conversion, and increased Rx lift.

For more information, visit () and follow us on LinkedIn ().

Marcella Millet Sciorra
CMO
press@swoop.com